Serial Number 98604886
688

Registration Progress

Application Filed
Jun 17, 2024
Under Examination
Mar 18, 2025
Approved for Publication
Jan 21, 2025
Published for Opposition
Jan 21, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Sep 18, 2025 65 days

Trademark Image

Basic Information

Serial Number
98604886
Filing Date
June 17, 2024
Published for Opposition
January 21, 2025
Drawing Code
2

Status Summary

Current Status
Active
Status Code
688
Status Date
Mar 18, 2025
Application
Pending
Classes
005

Rights Holder

Mirum Pharmaceuticals, Inc.

03
Address
989 E Hillisde Blvd. Suite 300
Foster City, CA 94404

Ownership History

Mirum Pharmaceuticals, Inc.

Original Applicant
03
Foster City, CA

Mirum Pharmaceuticals, Inc.

Owner at Publication
03
Foster City, CA

Legal Representation

Attorney
Karl M. Zielaznicki, Esq.

USPTO Deadlines

Next Deadline
65 days remaining
NOA E-Mailed - SOU Required
Due Date
September 18, 2025
Extension Available
Until March 18, 2026

Application History

15 events
Date Code Type Description Documents
Apr 9, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Mar 18, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 24, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 24, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jan 24, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 24, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 24, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jan 21, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 21, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 15, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 25, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 24, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 25, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 25, 2024 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jun 17, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of metabolic disorders, namely, cerebrotendinous xanthomatosis (CTX)

Additional Information

Design Mark
The mark consists of three shaded lines of increasing lengths at a parallel slant, followed by a shaded, straight vertical line.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005